| MAX inactivation in small cell lung cancer disrupts MYC–SWI/SNF programs and is synthetic lethal with BRG1 OA Romero, M Torres-Diz, E Pros, S Savola, A Gomez, S Moran, C Saez, ... Cancer discovery 4 (3), 292-303, 2014 | 202 | 2014 |
| Multi-omics analysis identifies MGA as a negative regulator of the MYC pathway in lung adenocarcinoma P Llabata, Y Mitsuishi, PS Choi, D Cai, JM Francis, M Torres-Diz, ... Molecular Cancer Research 18 (4), 574-584, 2020 | 39 | 2020 |
| Modulation of CD22 protein expression in childhood leukemia by pervasive splicing aberrations: implications for CD22-directed immunotherapies S Zheng, E Gillespie, AS Naqvi, KE Hayer, Z Ang, M Torres-Diz, ... Blood Cancer Discovery, 2021 | 31 | 2021 |
| Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts L Schulz, M Torres-Diz, M Cortés-López, KE Hayer, M Asnani, SK Tasian, ... Genome biology 22 (1), 1-12, 2021 | 20 | 2021 |
| High-throughput mutagenesis identifies mutations and RNA binding proteins controlling CD19 splicing and CART-19 therapy resistance M Cortés-López, L Schulz, M Enculescu, C Paret, B Spiekermann, ... bioRxiv, 2021 | 19 | 2021 |
| MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1. Cancer Discov. 2014; 4: 292–303. doi: 10.1158/2159-8290 OA Romero, M Torres-Diz, E Pros, S Savola, A Gomez, S Moran, C Saez, ... CD-13-0799.[Abstract][CrossRef][Google Scholar], 0 | 17 | |
| MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex P Llabata, M Torres-Diz, A Gomez, L Tomas-Daza, OA Romero, ... Proceedings of the National Academy of Sciences 118 (37), 2021 | 10 | 2021 |
| Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming OA Romero, S Verdura, M Torres-Diz, A Gomez, S Moran, E Condom, ... Oncogene 36 (9), 1287-1296, 2017 | 9 | 2017 |
| MYC Hyperactivates Wnt Signaling in APC/CTNNB1-Mutated Colorectal Cancer Cells through miR-92a–Dependent Repression of DKK3 P Sehgal, C Lanauze, X Wang, KE Hayer, M Torres-Diz, NA Leu, Y Sela, ... Molecular Cancer Research 19 (12), 2003-2014, 2021 | 8 | 2021 |
| Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4–LEF1 Binding CB Lanauze, P Sehgal, K Hayer, M Torres-Diz, JA Pippin, SFA Grant, ... Molecular Cancer Research 19 (5), 823-833, 2021 | 3 | 2021 |
| A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1 A Closa, M Reixachs-Solé, AC Fuentes-Fayos, KE Hayer, JL Melero, ... bioRxiv, 2021 | 1 | 2021 |
| P3. 02-086 MGA Suppresses the MYC Pathway in Lung Adenocarcinoma P Llabata, Y Mitsuishi, P Choi, M Torres-Diz, D Cai, X Zhang, ... Journal of Thoracic Oncology 12 (11), S2268-S2269, 2017 | 1 | 2017 |
| Max inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1 OA Romero-Ferraro, M Torres-Diz, E Pros, AG Moruno, SM Salama, ... Cancer Research 74 (19 Supplement), 2477-2477, 2014 | 1 | 2014 |
| MA17. 05 DNA-Binding and Gene Expression Profiles in Max Deficient Small Cell Lung Cancer P Llabata, M Torres-Diz, A Gomez, M Sanchez-Cespedes Journal of Thoracic Oncology 14 (10), S318, 2019 | | 2019 |
| Determination of sensitivity to BET and HDAC inhibitors in lung cancer cell lines S Verdura, M Torres-Diz, M Sanchez-Cespedes Cancer Research 77 (13 Supplement), 5073-5073, 2017 | | 2017 |
| Abstract A35: MAX inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1 M Torres-Diz, OA Romero, E Pros, S Savola, A Gomez, S Moran, ... Molecular Cancer Research 13 (10 Supplement), A35-A35, 2015 | | 2015 |
